Sin conexión a internet: se muestra la versión guardada de la página.

Revolution Medici…

USUSD
← Al screener

Revolution Medicines, Inc. (US:RVMD) — Biotechnology: Biological Products (No Diagnostic Substances). Número de bolsas en las que cotizan las acciones de la empresa: 1. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la empresa

Sitio web
revmed.com
Relaciones con los inversores
revmed.com/investors/
Sector
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Sede central
REDWOOD CITY, United States
Consejero delegado
Dr. Mark A. Goldsmith M.D., Ph.D.
Empleados
883
Fundada
2014
Acciones en circulación
214.34 M a 2026-07-31
Capital flotante
184.5 M
Capitalización bursátil
43.24 mil M USD
Insiders
1.85%
Inversores institucionales
101.01%
Industria (SIC)
Biological Products, (No Diagnostic Substances)
ISIN
US76155X1000
LEI
549300JU3X0LBCQ65892
Descripción

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Bolsas y tickers

BolsaTickerMonedaPrecioTipo
US USA StocksRVMDUSD199.87 -3.76%acciones ordinarias

Precio en 3 meses

US:RVMD · USD
día alcista día bajista fecha ex-dividendo fecha de pagoPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Dividendos

No se han encontrado pagos de dividendos (comprobado el 07.10.2026). Es probable que la empresa no reparta dividendos.

Noticias de esta semana

Aún no hay noticias del sitio web de la empresa.

anuncio

Principales accionistas

TitularParticipaciónAccionesFecha del informe
Blackrock Inc.6.39%13.7 M2026-06-30
Farallon Capital Managem…6.32%13.55 M2026-06-30
FMR, LLC5.69%12.2 M2026-06-30
Baker Bros. Advisors, LP5.34%11.44 M2026-06-30
Jupiter Topco LLC5.01%10.74 M2026-06-30
Darwin Global Management…4.96%10.63 M2026-06-30
Vanguard Capital Managem…4.24%9.09 M2026-06-30
Vanguard Portfolio Manag…3.87%8.29 M2026-06-30
Nextech Invest, Ltd.3.55%7.6 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.99%6.41 M2026-06-30
Paradigm Biocapital Advi…2.97%6.36 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.16%4.63 M2026-06-30
Growth Fund of America1.38%2.96 M2026-06-30
VANGUARD INDEX FUNDS-Van…1.25%2.67 M2026-06-30
Fidelity Mt. Vernon Stre…1.15%2.47 M2026-07-31
BORISY ALEXIS (Director)≈1.09%2.34 M2026-06-18
VANGUARD INDEX FUNDS-Van…1.07%2.29 M2026-06-30
VANGUARD SPECIALIZED FUN…0.86%1.84 M2026-04-30
iShares Trust-iShares Bi…0.65%1.39 M2026-07-31
JPMorgan Trust II-JPMorg…0.54%1.17 M2026-06-30
iShares Trust-iShares Ru…0.51%1.1 M2026-07-31
GOLDSMITH MARK A (Chief…≈0.46%984 2382026-08-21
KELSEY STEPHEN MICHAEL (…≈0.14%291 8762026-09-11
HORN MARGARET A (Chief O…≈0.07%154 6472026-06-17
ANDERS JACK LEE (Chief F…≈0.06%123 2692026-06-24
WANG XIAOLIN (Officer)≈0.05%116 0632026-03-17
LIN WEI (Officer)≈0.05%101 3662026-03-17
HORNING SANDRA (Director…≈0.05%97 7652026-06-18
CISLINI JEFFREY TODD (Ge…≈0.03%55 9072026-08-21
SCHROEDER THILO (Directo…——2024-12-05